NKY Medical Holdings Ltd Class A 300109
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 21.27
- Day Range
- CNY 20.33–21.20
- 52-Week Range
- CNY 12.03–27.26
- Bid/Ask
- CNY 20.85 / CNY 20.86
- Market Cap
- CNY 6.73 Bil
- Volume/Avg
- 12.0 Mil / 9.2 Mil
Key Statistics
- Price/Earnings (Normalized)
- 15.50
- Price/Sales
- 4.17
- Dividend Yield (Trailing)
- 2.35%
- Dividend Yield (Forward)
- 2.35%
- Total Yield
- 2.40%
Company Profile
NKY Medical Holdings Ltd develops and manufactures polyvinylpyrrolidone (PVP) series products in China. Its products can be used in Pharmaceutical accessories, hair gel, wine products stabilizer, water treatment, glue stick, and oral care products.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Mid Core
- Total Number of Employees
- 1,165
- Website
- http://www.boai-nky.com
Comparables
Valuation
|
Metric
|
300109
|
600211
|
301281
|
|---|---|---|---|
Price/Earnings (Normalized) | 15.50 | 12.02 | 39.94 |
Price/Book Value | 1.83 | 3.51 | 2.08 |
Price/Sales | 4.17 | 3.75 | 5.79 |
Price/Cash Flow | 13.14 | 9.57 | 21.99 |
Price/Earnings
300109
600211
301281
Financial Strength
|
Metric
|
300109
|
600211
|
301281
|
|---|---|---|---|
Quick Ratio | 1.93 | 2.74 | — |
Current Ratio | 2.94 | 2.87 | — |
Interest Coverage | 248.10 | 74.52 | — |
Quick Ratio
300109
600211
301281
Profitability
|
Metric
|
300109
|
600211
|
301281
|
|---|---|---|---|
Return on Assets (Normalized) | 12.78% | 17.12% | 3.70% |
Return on Equity (Normalized) | 14.59% | 23.66% | 4.08% |
Return on Invested Capital (Normalized) | 14.12% | 19.20% | 4.08% |
Return on Assets
300109
600211
301281
Drug Manufacturers - General Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
LLY
| Eli Lilly and Co | Hvhbssgj | Qlvm | $697.4 Bil | |
JNJ
| Johnson & Johnson | Nggdsth | Qtf | $353.8 Bil | |
MRK
| Merck & Co Inc | Mqqwqfrlj | Nzh | $332.3 Bil | |
ABBV
| AbbVie Inc | Gnwxylb | Vtfrq | $282.6 Bil | |
AZN
| AstraZeneca PLC ADR | Cpdnxbqlx | Zmdl | $232.3 Bil | |
NVS
| Novartis AG ADR | Fnpwglppn | Xfvzv | $200.1 Bil | |
RHHBY
| Roche Holding AG ADR | Wvjcmtncbr | Mmpc | $195.3 Bil | |
AMGN
| Amgen Inc | Hsybwkrb | Vjb | $144.5 Bil | |
PFE
| Pfizer Inc | Fsdsnttm | Dqsz | $143.8 Bil | |
SNY
| Sanofi SA ADR | Mbrlpvxt | Zbb | $122.2 Bil |